Disseminated bartonellosis and EBV reactivation in an adolescent treated with upadacitinib
Bartonella henselae infection should be suspected in immunocompromised patients presenting with fever of unknown origin. Upadacitinib is responsible for rapid immunodepression, which can lead to viral reactivation and severe bacterial infections. Randomized controlled trials are needed to establish a consensus on treatments for the various forms of Bartonellosis.
Authors
- Soumaya Skalli
- Hortense Petat (ORCID: https://orcid.org/0000-0003-2843-871X)
- Abdeljalil Zeggay (ORCID: https://orcid.org/0000-0002-4589-404X)
- Vincent Pargny
- Emilie Delugre
- Raphael Janela
Institutions
- Inserm (FR)
- Normandie Université (FR)
- Centre Hospitalier Universitaire de Rouen (FR)
- Université de Rouen Normandie (FR)
Publication Details
- Journal
- The Brazilian Journal of Infectious Diseases
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1016/j.bjid.2025.104536
- Citations
- 1
- Primary Topic
- Bartonella species infections research
- Type
- article
- Field-Weighted Citation Impact
- 2.05